A simple, robust and high‐throughput LC–MS/MS method for the therapeutic drug monitoring of polymyxin B1, polymyxin B2, polymyxin B3, isoleucine‐polymyxin B1, polymyxin E1 and polymyxin E2 in human plasma

Documents similaires

• Lipid A in outer membrane vesicles shields bacteria from polymyxins
  par: Marie Burt, et autres
  Publié: (2024)
• Impact of the national shortage of polymyxin B in critically ill patients during the COVID-19 pandemic
  par: Fernanda Piazza Fernandes
  Publié: (2023)
• An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma
  par: Xuli Lang, et autres
  Publié: (2024)
• A simple and sensitive LC–MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysis
  par: Panpan Wang, et autres
  Publié: (2024)
• Quantitation of the DNA‐dependent protein kinase inhibitor peposertib (M3814) and metabolite in human plasma by LC–MS/MS
  par: Susan M. Christner, et autres
  Publié: (2024)